Hyderabad Telangana, India

Rajesh Joshi

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Mylan Laboratories Limited. Active years: 2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rajesh Joshi. Retrieved from https://idiyas.com/inventor/rajesh-joshi-e1ohr4t9

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rajesh Joshi: Innovator in Pharmaceutical Patents

Introduction

Rajesh Joshi is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative drug formulations. His work has been instrumental in advancing medical treatments and improving patient outcomes.

Latest Patents

Rajesh Joshi holds a patent for "Polymorphic forms of VENCLEXTA." This patent relates to crystalline forms of venetoclax and the processes for their preparation. Additionally, it covers the process for the preparation of amorphous venetoclax. This innovation is crucial for enhancing the efficacy and stability of the drug.

Career Highlights

Rajesh is currently employed at Mylan Laboratories Limited, a leading global pharmaceutical company. His role involves research and development, where he focuses on creating new pharmaceutical formulations that can benefit patients worldwide. His expertise in the field has led to the successful development of various drug formulations.

Collaborations

Some of his notable coworkers include Ramakoteswara Rao Jetti and Hemant Malhari Mande. Together, they have collaborated on various projects aimed at advancing pharmaceutical research and development.

Conclusion

Rajesh Joshi's contributions to the pharmaceutical industry through his innovative patents and collaborative efforts highlight his commitment to improving healthcare. His work continues to impact the field positively, paving the way for future advancements in drug development.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…